Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
letter
. 1981 Jul;73(7):601–607.

Hepatocellular Carcinoma—Etiologic Considerations: A Review of the Literature

Roger G Worrell, Mohamad Moazami, Louise A Worrell
PMCID: PMC2553017  PMID: 6267318

Abstract

There are an estimated 120 million hepatitis B virus carriers worldwide. More than 200,000 of these are in the United States. A higher incidence of active hepatitis B virus infection has been observed in patients with hepatocellular carcinoma than in controls, in all geographical regions. This paper reviews the world literature on the relationship of hepatitis B virus to the pathogenesis of hepatocellular carcinoma.

Full text

PDF
601

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter H. J., Purcell R. H., Holland P. V., Popper H. Transmissible agent in non-A, non-B hepatitis. Lancet. 1978 Mar 4;1(8062):459–463. doi: 10.1016/s0140-6736(78)90131-9. [DOI] [PubMed] [Google Scholar]
  2. Anthony P. P. Precancerous changes in the human liver. J Toxicol Environ Health. 1979 Mar-May;5(2-3):301–313. doi: 10.1080/15287397909529751. [DOI] [PubMed] [Google Scholar]
  3. Blumberg B. S., Larouzé B., London W. T., Werner B., Hesser J. E., Millman I., Saimot G., Payet M. The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am J Pathol. 1975 Dec;81(3):669–682. [PMC free article] [PubMed] [Google Scholar]
  4. Chen D. S., Sung J. L. Hepatitis B virus infection and chronic liver disease in Taiwan. Acta Hepatogastroenterol (Stuttg) 1978 Dec;25(6):423–430. [PubMed] [Google Scholar]
  5. Desmyter J., Bradburne A. F., Vermylen C., Daneels R., Boelaert J. Hepatitis-B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients. Lancet. 1975 Aug 30;2(7931):376–377. [PubMed] [Google Scholar]
  6. Desmyter J., De Groote J., Desmet V. J., Billiau A., Ray M. B., Bradburne A. F., Edy V. G., De Somer P. Administration of human fibroblast interferon in chronic hepatitis-B infection. Lancet. 1976 Sep 25;2(7987):645–647. doi: 10.1016/s0140-6736(76)92460-0. [DOI] [PubMed] [Google Scholar]
  7. Drucker J. A., Coursaget P., Maupas P., Goudeau A., Gerety R. J., Chiron J. P., Denis F., Diop Mar I. Hepatitis A infection and primary hepatocellular carcinoma. Biomedicine. 1979 Feb;31(1):23–25. [PubMed] [Google Scholar]
  8. Greenberg H. B., Pollard R. B., Lutwick L. I., Gregory P. B., Robinson W. S., Merigan T. C. Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med. 1976 Sep 2;295(10):517–522. doi: 10.1056/NEJM197609022951001. [DOI] [PubMed] [Google Scholar]
  9. Kew M. C., Geddes E. W., Macnab G. M., Bersohn I. Hepatitis-B antigen and cirrhosis in Bantu patients with primary liver cancer. Cancer. 1974 Sep;34(3):538–541. doi: 10.1002/1097-0142(197409)34:3<539::aid-cncr2820340310>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  10. Krugman S., Giles J. P., Hammond J. Viral hepatitis, type B (MS-2 strain). Studies on active immunization. JAMA. 1971 Jul 5;217(1):41–45. [PubMed] [Google Scholar]
  11. Krugman S., Gocke D. J. Viral hepatitis. Major Probl Intern Med. 1978;15:1–147. [PubMed] [Google Scholar]
  12. Kubo Y., Okuda K., Musha H., Nakashima T. Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease: observations in 31 patients. Gastroenterology. 1978 Mar;74(3):578–582. [PubMed] [Google Scholar]
  13. Lee F. I. Cirrhosis and hepatoma in alcoholics. Gut. 1966 Feb;7(1):77–85. doi: 10.1136/gut.7.1.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lehmann F. G., Wegener T. Etiology of human liver cancer: controlled prospective study in liver cirrhosis. J Toxicol Environ Health. 1979 Mar-May;5(2-3):281–299. doi: 10.1080/15287397909529750. [DOI] [PubMed] [Google Scholar]
  15. London W. T. Hepatocellular carcinoma (an approach to the study of risk factors in human cancer). Ric Clin Lab. 1978 Oct-Dec;8(4):232–236. [PubMed] [Google Scholar]
  16. Lutwick L. I. Relation between aflatoxin, hepatitis-B virus, and hepatocellular carcinoma. Lancet. 1979 Apr 7;1(8119):755–757. doi: 10.1016/s0140-6736(79)91210-8. [DOI] [PubMed] [Google Scholar]
  17. Macdougall B. R., Johnson P. J., Williams R., Strunin L., Macmaster P., Calne R. Y., Bronkhorst F. B., Katchaki J. N., Brandt K. H., Houthoff H. J. Liver transplantation in a 27-year-old female with familial HBsAg-positive hepatocellular carcinoma. Neth J Med. 1978;21(3):101–116. [PubMed] [Google Scholar]
  18. Maugh T. H., 2nd Hepatitis B: a new vaccine ready for human testing. Science. 1975 Apr 11;188(4184):137–138. doi: 10.1126/science.188.4184.137. [DOI] [PubMed] [Google Scholar]
  19. McCaughan G., Parsons C., Gallagher N. D. Primary hepatocellular carcinoma in Australia: Aetiological considerations. Med J Aust. 1979 Apr 21;1(8):304–306. doi: 10.5694/j.1326-5377.1979.tb112117.x. [DOI] [PubMed] [Google Scholar]
  20. OUCHTERLONY O. Antigen-antibody reactions in gels. Acta Pathol Microbiol Scand. 1949;26(4):507–515. doi: 10.1111/j.1699-0463.1949.tb00751.x. [DOI] [PubMed] [Google Scholar]
  21. Okuda K., Nakashima T. Hepatocellular carcinoma: a review of the recent studies and developments. Prog Liver Dis. 1979;6:639–650. [PubMed] [Google Scholar]
  22. Olweny C. L., Toya T., Katongole-Mbidde E., Mugerwa J., Kyalwazi S. K., Cohen H. Treatment of hepatocellular carcinoma with adriamycin. Preliminary communication. Cancer. 1975 Oct;36(4):1250–1257. doi: 10.1002/1097-0142(197510)36:4<1250::aid-cncr2820360410>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  23. Omata M., Ashcavai M., Liew C. T., Peters R. L. Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens. Gastroenterology. 1979 Feb;76(2):279–287. [PubMed] [Google Scholar]
  24. Popper H. Hepatic cancers in man: quantitative perspectives. Environ Res. 1979 Aug;19(2):482–494. doi: 10.1016/0013-9351(79)90072-0. [DOI] [PubMed] [Google Scholar]
  25. Prince A. M., Szmuness W., Mann M. K., Vyas G. N., Grady G. F., Shapiro F. L., Suki W. N., Friedman E. A., Stenzel K. H. Hepatitis B "immune" globulin: effectiveness in prevention of dialysis-associated hepatitis. N Engl J Med. 1975 Nov 20;293(21):1063–1067. doi: 10.1056/NEJM197511202932103. [DOI] [PubMed] [Google Scholar]
  26. Purcell R. H. The viral hepatitides. Hosp Pract. 1978 Jul;13(7):51–63. doi: 10.1080/21548331.1978.11707370. [DOI] [PubMed] [Google Scholar]
  27. Redeker A. G., Mosley J. W., Gocke D. J., McKee A. P., Pollack W. Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis. N Engl J Med. 1975 Nov 20;293(21):1055–1059. doi: 10.1056/NEJM197511202932101. [DOI] [PubMed] [Google Scholar]
  28. Shikata T. Pathology and pathogenesis of viral hepatitis. Southeast Asian J Trop Med Public Health. 1978 Jun;9(2):171–176. [PubMed] [Google Scholar]
  29. Su D. Drinking water and liver cell cancer: an epidemiologic approach to the etiology of this disease in China. Chin Med J (Engl) 1979 Nov;92(11):748–756. [PubMed] [Google Scholar]
  30. Surgenor D. M., Chalmers T. C., Conrad M. E., Friedewald W. T., Grady G. F., Hamilton M., Mosley J. W., Prince A. M., Stengle J. M. Clinical trials of hepatitis B immune globulin. Development of policies and materials for the 1972-1975 studies sponsored by the National Heart and Lung Institute. N Engl J Med. 1975 Nov 20;293(21):1060–1062. doi: 10.1056/NEJM197511202932102. [DOI] [PubMed] [Google Scholar]
  31. Tong M. J., McPeak C. M., Thursby M. W., Schweitzer I. L., Henneman C. E., Ledger W. J. Failure of immune serum globulin to prevent hepatitis B virus infection in infants born to HBsAg-positive mothers. Gastroenterology. 1979 Mar;76(3):535–539. [PubMed] [Google Scholar]
  32. Trichopoulos D., Tabor E., Gerety R. J., Xirouchaki E., Sparros L., Munoz N., Linsell C. A. Hepatitis B and primary hepatocellular carcinoma in a European population. Lancet. 1978 Dec 9;2(8102):1217–1219. doi: 10.1016/s0140-6736(78)92097-4. [DOI] [PubMed] [Google Scholar]
  33. Zuckerman A. J. Role of hepatitis B virus in primary liver cancer. J Toxicol Environ Health. 1979 Mar-May;5(2-3):275–280. doi: 10.1080/15287397909529749. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES